320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM

Journal article

Peer reviewed

R. Komrokii, A. Zeidan, N. Al Ali, E. Padron, J. Lancet, D. Steensma, A. Dezern, G. Roboz, E. Jabbour, M. Sekeres, …

Leukemia research, Vol.39, pp.S158-S159

2015-04

Metrics

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.155 Acute Myeloid Leukemia
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM
Creators: R. Komrokii
A. Zeidan
N. Al Ali
E. Padron
J. Lancet
D. Steensma
A. Dezern
G. Roboz
E. Jabbour
M. Sekeres
G. Garcia-Manero
A. List
Publication Details: Leukemia research, Vol.39, pp.S158-S159
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757790302976